Pneumonia, Bacterial  >>  Solithera (solithromycin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
SOLITAIRE-ORAL, NCT01756339 / 2012-003971-20: Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Completed
3
860
US, Canada, Europe, RoW
Solithromycin, CEM-101, Moxifloxacin, Avelox, Placebo to match solithromycin
Melinta Therapeutics, Inc.
Community-acquired Bacterial Pneumonia
10/14
10/14
SOLITAIRE-IV, NCT01968733 / 2013-003453-13: Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Completed
3
863
US, Canada, Europe, RoW
Solithromycin, CEM-101, Moxifloxacin, Avelox
Melinta Therapeutics, Inc.
Community-acquired Bacterial Pneumonia
07/15
09/15

Download Options